MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Pioneers: Research_Academia, Government Labs, Non-Profits, Industry
*Pioneers: Cardiology & Cardiovascular (Diseases)
*Pioneers: Cardiology & Cardiovascular (Vulnerable Plaque)
Advanced Imaging-T5/UTHSC
Parents
*Pioneers: Cardiology & Cardiovascular (Vulnerable Plaque)
*Pioneers: Medical Imaging_Cardiology & Cardiovascular (Imaging)
Nano-Diagnostics & imaging
Nanomedicine Programs
Pioneers: Research_Academia, Government Labs, Non-Profits, Industry
T5-Texas Training & Technology for Trauma & Terrorism -UTHSC
UTHSC:R&D
Children
1) Selectively delivered to regions of interest,
2) Concentrate there for diagnostic imaging,
3)Remain there for therapeutic release of encapsulated drugs.
Better understand blush sign indicators that can be obtained in contrast CT.
CT & Nanomaterial-based Contrast Agents-UTHSC
Dr Richard Smalley-Nobel Laureate (Deceased)
Dr S. Ward Casscells, III, MD, former, Assistant Secretary of Defense, Health Affairs-UTHSC
Dr. James T. Willerson, President & Medical Director of the Texas Heart Institute & CEO, UTHSC
New algorithms capable of providing spatial representations of the vasculature and subsequently map out areas of coronary calcif
Novel contrast agents:
Software-based approaches to identify leaky angiogenesis where plaques possess heightened vulnerability
Synthetic formulations of nanomaterials that possess therapeutic, contrast enhancement, and/or targeting characteristics
Use of advanced medical imaging, high-risk calcification and vulnerable plaques can be accurately detected
Jumps
APP-American Pharmaceuticals Partner, Inc
Quantum Molecular Pharmaceuticals, Inc.